Retatrutide has emerged as a new medication in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By activating these https://theresawrnb062454.blogminds.com/tirzepatide-a-promising-new-treatment-for-obesity-33142985